Editas Medicine, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Editas Medicine, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Editas Medicine, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $3.85M, a 1.28% decline year-over-year.
  • Editas Medicine, Inc. annual Operating Lease, Payments for 2023 was $12.4M, a 16.3% decline from 2022.
  • Editas Medicine, Inc. annual Operating Lease, Payments for 2022 was $14.9M, a 13.4% increase from 2021.
  • Editas Medicine, Inc. annual Operating Lease, Payments for 2021 was $13.1M, a 34.2% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.85M -$50K -1.28% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $3.9M +$151K +4.03% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $3.75M -$502K -11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q1 2021 $4.25M +$1.71M +67.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $2.54M +$814K +47.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $1.72M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.